Jane Street’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Jane Street’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-161,113	Closed	-$659K	–	10399
2024 Q1	$659K	Buy	161,113 +36,087	+29%	+$161K	﹤0.01%	6171
2023 Q4	$731K	Buy	125,026 +112,543	+902%	+$592K	﹤0.01%	6132
2023 Q3	$64.3K	Buy	+12,483	New	+$58.6K	﹤0.01%	8089

Other funds holding AUGX

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Jane Street's AUGX Position: Q2 2024 in Review

Jane Street sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 161,113 shares — an estimated $659K sold.

Jane Street first reported a position in AUGX in Q3 2023 and held it in 3 quarters. The position peaked at $731K in Q4 2023. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

Jane Street reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jane Street sold 161,113 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $659K.
Jane Street first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Jane Street's Augmedix, Inc. Common Stock position peaked at $731K in Q4 2023.
52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.